EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Peripheral Inflammation as a Biomarker of Disease Activity in Relapsing-Remitting MS

Abdulsattar Hussein Abdullah

Neurosignals · 2025

DOI: 10.33594/000000814 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Neurosignals, 2025. Verfasst von Abdulsattar Hussein Abdullah. Beteiligte Einrichtung: Department of Medicine, College of Medicine, University of Tikrit, Iraq, E-Mail: abdalsatarhussein@tu.edu.iq. Hauptthemen laut MEDLINE: Multiple Sclerosis, Relapsing-Remitting, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Relapsing-remitting multiple sclerosis (RRMS) is a chronic autoimmune disorder of the central nervous system, marked by unexpected episodes of neurological impairment and inflammation. Peripheral inflammatory indicators are becoming recognized as noninvasive predictors of disease activity, progression, and subsequent assessment, complementing traditional clinical and radiographic evaluations. To examine the correlations between disease activity and peripheral inflammatory biomarkers—interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), high-sensitivity C-reactive protein (hs-CRP), erythrocyte sedimentation rate (ESR), and serum neurofilament light chain (sNfL)—in patients with relapsing-remitting multiple sclerosis (RRMS).

Methods

Prospective observational research encompassed 250 RRMS patients from January 2024 to May 2025, who attended Tikrit Teaching Hospital and private neurology clinics. Patients received baseline and 12-month MRI scans, together with a clinical evaluation utilizing the Expanded Disability Status Scale (EDSS). Inflammatory markers and sNfL were assessed in peripheral blood samples. Investigations were conducted on the correlations among biomarkers, clinical impairment, and MRI lesion burden.

Results

The average age of the population studied was 34.6 ± 8.7 years, and 64% of patients were women. Elevation of IL-6 (4.8 ± 2.0 pg/mL), TNF-α (6.1 ± 2.3 pg/mL), and hs-CRP and ESR sNfL (18.5 ± 6.4 pg/mL) with a positive correlation to EDSS score and MRI lesional load (p < 0.05) was observed. MRI showed a reduction in inflammatory lesions, whereas the number of black T1 holes increased over 12 months (indicating ongoing neurodegeneration).

Conclusion

Soluble NfL, IL-6, and TNF-α are convenient markers of inflammation to reflect signal relay disease activity in RRMS. Their association with the clinical and radiographic findings may assist in personalizing the therapeutic approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple Sclerosis, Relapsing-RemittingInflammationHumansFemaleAdultBiomarkersMaleInterleukin-6Middle AgedTumor Necrosis Factor-alphaProspective StudiesC-Reactive ProteinNeurofilament ProteinsBlood SedimentationMagnetic Resonance ImagingDisease Progression

Stichwörter der Autor:innen

Relapsing-Remitting Multiple Sclerosis; Peripheral Inflammation; Biomarkers; Ne…

Substanzen

BiomarkersInterleukin-6Tumor Necrosis Factor-alphaC-Reactive ProteinNeurofilament Proteinsneurofilament protein LIL6 protein, human

Autor:innen und Institutionen

  • Department of Medicine, College of Medicine, University of Tikrit, Iraq, E-Mail: abdalsatarhussein@tu.edu.iq.

Zitieren

APA

Abdullah, A. H. (2025). Peripheral Inflammation as a Biomarker of Disease Activity in Relapsing-Remitting MS. Neurosignals. https://doi.org/10.33594/000000814

Vancouver

Abdullah AH. Peripheral Inflammation as a Biomarker of Disease Activity in Relapsing-Remitting MS. Neurosignals. 2025. doi:10.33594/000000814

BibTeX
@article{Abdullah2025,
  author = {Abdullah, Abdulsattar Hussein},
  title = {Peripheral Inflammation as a Biomarker of Disease Activity in Relapsing-Remitting MS},
  journal = {Neurosignals},
  year = {2025},
  doi = {10.33594/000000814}
}
Kostenlos starten →